Heart Disease and Women

Heart disease is the leading cause of death for women in the United States, killing approximately 1 in 4 women* within the first year, compared to 1 in 5 men.
In addition, female heart patients required longer hospital stays and incurred higher medical bills than males.

Medicine WISE’s Up

The EndoPAT™

The EndoPAT™

Heart disease is not gender neutral, according to findings from the Women’s Ischemia Syndrome Evaluation (WISE) study, the landmark investigation into ischemic heart disease in women.
Discoveries from the WISE study suggest that many women have coronary microvascular dysfunction that is not detected by standard diagnostic procedures and therefore goes unrecognized and untreated.
Heart attacks are less likely to occur in pre-menopausal women than in age-matched men, a benefit attributed to estrogen. But doctors also assumed that when women developed heart disease it was atherosclerotic plaque restricting blood flow in the coronaries. Consequently, procedures to diagnose and treat heart disease were biased on research conducted in male-only studies.

In the 1970s, a study conducted by the National Institutes of Health launched the Coronary Artery Surgery found that women with a positive stress test was 4.5 times more likely than men with a positive stress test to have an angiogram showing no blockages.
*Facts on Women and Heart Disease, Centers for Disease Control and Prevention, 2015

Microvessel Disease (Vascular Dysfunction)

Medicine WISE’s Up

The EndoPAT™

According to the WISE study, many symptomatic women with positive stress tests had negative angiograms. But many of these women also had abnormal results on vascular function tests. Their coronary arteries and smaller vessels feeding the heart muscle didn’t dilate properly and thus couldn’t accommodate increased blood flow, indicating vascular dysfunction.
Vascular dysfunction occurred both in women with clear arteries and in those with obvious coronary artery narrowing. Moreover, it was not a problem of the large coronary arteries alone, but involved stiffening of the network of smaller vessels that also nourish the heart.
This condition has since been called coronary microvascular dysfunction, or microvessel disease, and is sometimes referred to as Syndrome X.
To some cardiologists, the discovery of widespread microvessel disease helped explain why so many women with IHD were misdiagnosed and undertreated: The standard protocol identified only coronary artery obstructions.
Microvessel disease could also help explain why so few women have the classic crushing chest pain that signals coronary artery disease. Instead, women have other symptoms that are nonspecific and less dramatic than those that herald a blockage caused by a blood clot.

Heart Attack Symptoms in Women

  • Heavy sharp chest pain or discomfort
  • Upper abdomen or back pain
  • Pain in the neck / jaw / throat
  • Shortness of breath
  • Indigestion, heartburn, nausea / vomiting
  • Some women have no symptoms of heart disease.
    Sometimes heart disease may be silent and not diagnosed until a woman has signs or symptoms
  • Upper body discomfort
  • Shortness of breath

The WISE data may also explain why women who undergo angioplasty and bypass surgery don’t fare as well as men. These women may have both coronary artery disease and unrecognized microvessel disease. In such cases, opening the arteries isn’t sufficient.

Probing the Pathology

How and why does coronary microvascular syndrome develop? Inflammation is a prime suspect. Not only is inflammation implicated in atherosclerosis, but it’s also at the heart of inflammatory disorders, such as autoimmune diseases, which are far more common in women than in men.
The WISE researchers, led by Noel Bairey Merz, M.D. of Cedars-Sinai Medical Center in Los Angeles, reported that three proteins associated with inflammation—C-reactive protein (CRP), interleukin-6 (IL-6), and serum amyloid A (SAA)—were particularly important.
Dr. Bairey Merz has an EndoPAT and has been advising Itamar Medical over the years on heart-related medical issues.
Compared to women with low levels of these proteins, women with the highest levels were at much greater risk for a coronary event or death within five years—even though they were only slightly more likely to have coronary artery blockages. This led to the idea that inflammatory markers could help assess microvessel disease in women.
Autopsy studies support this approach. They show that women who die of heart attacks often have a pathology different from that of their male counterparts. In men, plaque tends to form in isolated accumulations that push into the lumen or burrow into the artery wall.
In women, plaque is more likely to be deposited uniformly around the inside of the vessel—the possible handiwork of chronic inflammation.
When inflammatory substances course chronically through the bloodstream, they strip away cells that line the blood vessels, creating an ideal bed for cholesterol-laden plaque. The plaque gave these women’s vessels stiff interior walls that tended not to rupture under stress, which is a common characteristic of the male heart attack, but to erode. Efforts to repair the erosion perpetuate the inflammatory cycle and spur the formation of tiny blood clots, a possible trigger for heart attacks resulting from microvessel disease.


Beyond Inflammation

The EndoPAT™

Beyond Inflammation

Inflammation isn’t the only cause of coronary microvascular dysfunction. The WISE researchers looked at the classic cardiovascular risk factors and found that all the usual suspects—genes, high LDL cholesterol, low HDL cholesterol, high triglycerides, elevated blood sugar, hypertension, sedentary lifestyle, and obesity—were implicated. They uncovered some other risk factors as well, including these:

  • Premenopausal high blood pressure. Hypertension, particularly in younger women, is a major risk factor for IHD. It damages the cells lining the coronary vessels, which attracts immune cells that trigger and feed inflammation.
  • Anemia. The WISE study determined that cardiovascular outcomes are worse for anemic women than for women with normal hemoglobin levels. Anemia leaves fewer red blood cells to supply the heart muscle with oxygen.
  • Polycystic ovarian syndrome (PCOS). Women with PCOS have many components of the metabolic syndrome along with erratic levels of circulating estrogen. Estrogen may dampen inflammation, so when too little is available, the risk of heart disease may rise, especially in premenopausal women.

Talk To Your Patients And Reassess Risks

If you have a patient at high risk for or have symptoms of heart disease, such as unexplained fatigue or shortness of breath, discuss the WISE findings with your patients. You may want to reevaluate their care, especially if they’ve had a “false-positive” stress test.
Even if your patients are not at risk for coronary artery disease, the chance of an early cardiac event might be elevated by microvessel disease.
EndoPAT™ can play an important role here.


Back to main EndoPAT page
Key Features
PAT™ (Peripheral Arterial Tone) Technology
Risk for Atherosclerosis
Endothelial Dysfunction
Women’s Heart
Wellbeing & arterial health
Physicians’ Case Studies